Señales en vivo de 300147.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 23:38):

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China...

Stats
Volumen de hoy	9.58M
Volumen promedio	20.32M
Capitalización de mercado	2.40B
EPS	CNY-0.155 ( 2023-06-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-6.28
ATR14	CNY0.00900 (0.25%)

Volumen Correlación

Largo: -0.12 (neutral)

Corto: 0.86 (strong)

Signal:(52.794) Same movement expected

Xiangxue Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Xiangxue Pharmaceutical Correlación - Moneda/Commodity

0.51
( weak )

0.09
( neutral )

0.00
( neutral )

0.14
( neutral )

0.00
( neutral )

0.46
( neutral )

Xiangxue Pharmaceutical Finanzas

Annual	2022
Ingresos:	CNY2.19B
Beneficio Bruto:	CNY542.51M (24.81 %)
EPS:	CNY-0.770

FY	2022
Ingresos:	CNY2.19B
Beneficio Bruto:	CNY542.51M (24.81 %)
EPS:	CNY-0.770

FY	2021
Ingresos:	CNY2.97B
Beneficio Bruto:	CNY779.28M (26.23 %)
EPS:	CNY-1.049

FY	2020
Ingresos:	CNY3.07B
Beneficio Bruto:	CNY992.57M (32.31 %)
EPS:	CNY0.150

Financial Reports:

No articles found.

Xiangxue Pharmaceutical

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. The company was founded in 1997 and is based in Guangzhou, China.